Akio Fujimura

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 6

Top Topics

Pulmonary Arterial Hypertension

Electronic Health Record

Top Venues

Chronobiology international

Clinical and experimental pharmacology & physiology

Expert review of clinical pharmacology

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Akio Fujimura, Kentaro Ushijima
Understanding the role of chronopharmacology for drug optimization: what do we know? Expert review of clinical pharmacology (2023)
Yuya Tsurudome, Takahiro Akamine, Michiko Horiguchi, Yukiyo Wada, Akio Fujimura, Kentaro Ushijima
Potential mechanism of hepatic lipid accumulation during a long-term rest phase restricted feeding in mice. Chronobiology international 39 (8) (2022)
Tatsuya Nagano, Kentaro Ushijima, Naoyuki Taga, Mamoru Takeuchi, Masa-Aki Kawada, Kenichi Aizawa, Yasushi Imai, Akio Fujimura
Influence of the aldehyde dehydrogenase 2 polymorphism on the vasodilatory effect of nitroglycerin in infants with congenital heart disease and pulmonary arterial hypertension. European journal of clinical pharmacology 75 (10) (2019)
Yusuke Arakawa, Kentaro Ushijima, Hiroyoshi Tsuchiya, Jun-Ichi Morishige, Akiko Mii, Hitoshi Ando, Shu-Ichi Tsuruoka, Akio Fujimura
Influence of renal ischaemia-reperfusion injury on renal neutrophil gelatinase-associated lipocalin receptor (24p3R) in rats. Clinical and experimental pharmacology & physiology 46 (12) (2019)
Kentaro Ushijima, Koichi Mizuta, Shinya Otomo, Keiko Ogaki, Yukihiro Sanada, Yuta Hirata, Yoshiyuki Ihara, Taizen Urahashi, Yasushi Imai, Akio Fujimura
Increased tacrolimus blood concentration by Beni-Madonna - a new hybrid citrus cultivar categorized as 'Tangor', in a liver transplant patient: likely furanocoumarin-mediated inhibition of CYP3A4 or P-glycoprotein. British journal of clinical pharmacology 84 (12) (2018)
Daisuke Yoshioka, Hitoshi Ando, Kentaro Ushijima, Masafumi Kumazaki, Akio Fujimura
Chronotherapy of maxacalcitol on skin inflammation induced by topical 12-O-tetradecanoylphorbol-13-acetate in mice. Chronobiology international 35 (9) (2018)